Ryan J. Selhorn - 03 Oct 2025 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Financial Officer
Signature
/s/ Ryan J. Selhorn
Issuer symbol
AYTU
Transactions as of
03 Oct 2025
Net transactions value
$0
Form type
4
Filing time
07 Oct 2025, 16:12:18 UTC
Previous filing
03 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Selhorn Ryan J Chief Financial Officer C/O AYTU BIOPHARMA, INC., 7900 EAST UNION AVENUE, SUITE 920, DENVER /s/ Ryan J. Selhorn 07 Oct 2025 0001670673

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Stock Award $0 +16,243 +102% $0.000000 32,243 03 Oct 2025 Direct F1
transaction AYTU Common Stock Award $0 +17,500 +54% $0.000000 49,743 03 Oct 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was granted fully vested restricted stock in lieu of cash in satisfaction of their annual bonus.
F2 Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027.

Remarks:

Exhibit 24: Power of Attorney